BioRestorative Announces Share Repurchase Program
OrthoSpineNews
JUNE 17, 2025
The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. We have also obtained U.S.
52 
Let's personalize your content